Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Iovance Biotherapeutics, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Taiho Oncology, Inc.
NRG Oncology
Eastern Cooperative Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
ToLymph Inc.
George Washington University
AstraZeneca
Shanghai Pulmonary Hospital, Shanghai, China
Emory University
NATCO Pharma Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Yonsei University
M.D. Anderson Cancer Center
Mayo Clinic
Cedars-Sinai Medical Center
Thomas Jefferson University
Genelux Corporation
Fudan University
Sun Yat-sen University
University of California, San Francisco
Jinling Hospital, China
Universitair Ziekenhuis Brussel
Fujian Cancer Hospital
The First Affiliated Hospital with Nanjing Medical University